These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36756249)

  • 21. Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies.
    Ma Y; Xiang H; Busse JW; Yao M; Guo J; Ge L; Li B; Luo X; Mei F; Liu J; Wang Y; Liu Y; Li W; Zou K; Li L; Sun X
    J Neurol; 2024 May; 271(5):2309-2323. PubMed ID: 38436679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
    Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial.
    Meng X; Li S; Dai H; Lu G; Wang W; Che F; Geng Y; Sun M; Li X; Li H; Wang Y
    JAMA; 2024 Nov; 332(17):1437-1445. PubMed ID: 39264623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel Occlusion: A Pooled Analysis of the EXTEND-IA TNK Trials.
    Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu TY; Shah DG; Ng FC; Dewey HM; Wijeratne T; Yan B; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2022 Mar; 98(12):e1292-e1301. PubMed ID: 35017305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
    Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
    Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial.
    Bala F; Singh N; Ignacio K; Alhabli I; Ademola A; Alrohimi A; Khosravani H; Tkach A; Catanese L; Dowlatshahi D; Field T; Hunter G; Benali F; Horn M; Demchuk A; Hill M; Sajobi T; Buck B; Swartz R; Almekhlafi M; Menon BK
    J Stroke; 2024 May; 26(2):280-289. PubMed ID: 38836275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.
    Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G
    Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative safety of tenecteplase vs alteplase for acute ischemic stroke.
    Flint AC; Eaton A; Melles RB; Hartman J; Cullen SP; Chan SL; Rao VA; Nguyen-Huynh MN; Kapadia B; Patel NU; Klingman JG
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107468. PubMed ID: 38039801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review.
    Potla N; Ganti L
    Int J Emerg Med; 2022 Jan; 15(1):1. PubMed ID: 34983359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial.
    Xiong Y; Wang L; Pan Y; Wang M; Schwamm LH; Duan C; Campbell BCV; Li S; Hao M; Wu N; Cao Z; Wu S; Li Z; Wang Y
    Stroke Vasc Neurol; 2024 Jun; ():. PubMed ID: 38858097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial.
    Nair R; Singh N; Kate M; Asdaghi N; Sarmiento R; Bala F; Coutts SB; Horn M; Poppe AY; Williams H; Ademola A; Alhabli I; Benali F; Khosravani H; Hunter G; Tkach A; Manosalva Alzate HA; Pikula A; Field T; Trivedi A; Dowlatshahi D; Catanese L; Shuaib A; Demchuk A; Sajobi T; Almekhlafi MA; Swartz RH; Menon B; Buck BH
    Stroke Vasc Neurol; 2024 Jan; ():. PubMed ID: 38296590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
    Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
    Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.
    Burgos AM; Saver JL
    Stroke; 2019 Aug; 50(8):2156-2162. PubMed ID: 31318627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanical thrombectomy alone versus with thrombolysis for ischemic stroke: A meta-analysis of randomized trials.
    Kobeissi H; Adusumilli G; Ghozy S; Bilgin C; Kadirvel R; Brinjikji W; Heit JJ; Rabinstein AA; Kallmes DF
    Interv Neuroradiol; 2023 Feb; ():15910199231154331. PubMed ID: 36734138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of tenecteplase and alteplase in acute ischemic stroke: A pairwise and network meta-analysis of randomized controlled trials.
    Rehman AU; Mohsin A; Cheema HA; Zahid A; Ebaad Ur Rehman M; Ameer MZ; Ayyan M; Ehsan M; Shahid A; Aemaz Ur Rehman M; Shah J; Khawaja A
    J Neurol Sci; 2023 Feb; 445():120537. PubMed ID: 36630803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different dosing regimens of Tenecteplase in acute ischemic stroke: A network meta-analysis of the clinical evidence.
    The EZ; Lin NN; Matar M; Teoh HL; Yeo LLL
    Eur Stroke J; 2023 Mar; 8(1):93-105. PubMed ID: 37021171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase.
    Ezzeldin M; Hill C; Kerro A; Percenti E; Delora A; Santos J; Saei H; Greco L; Ezzeldin R; El-Ghanem M; Alderazi Y; Kim Y; Poitevint C; Mir O
    Cureus; 2023 Oct; 15(10):e46889. PubMed ID: 37859677
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.